Picture of Biovica International AB logo

BIOVIC B Biovica International AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Biovica International AB, fiscal year end - April 30th, SEK millions except per share, conversion factor applied.

2021
April 30th
2022
April 30th
2023
April 30th
2024
April 30th
2025
April 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-39.4-60.1-110-127-85.8
Depreciation
Non-Cash Items0.1460.0520.0070.367-0.291
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.311.487.62.48-8.08
Change in Accounts Receivable
Change in Inventories
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-34.4-52.1-94.6-115-85.4
Capital Expenditures-3.56-3.4-2.78-0.146-0.287
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.4390
Purchase of Investments
Cash from Investing Activities-3.56-3.4-2.78-0.585-0.287
Financing Cash Flow Items-25.2-16.70.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities143-0.13612279.530.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash105-55.624.5-34.9-55